A study of chemotherapy induced perioheral neuropathy by SNPs

A study of chemotherapy induced perioheral neuropathy by SNPs - Peripehral neuropathy and SNPs

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005294

Enrollment

200

Registered

2011-04-01

Start date

2011-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast and epitherial ovarian cancer

Interventions

Peripheral blood to draw DNA

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: No previous history of taxane containing regimens sho will start taxane based chemotherapy regimens

Exclusion criteria

Exclusion criteria: Diabetes Metastases to brain Neuropathic patients

Design outcomes

Primary

Measure	Time frame
To identify risk of peripheral neuropathy by SNPs	—

Secondary

Measure	Time frame
Timing of appearance of neuropathy Timing of disappearance of neuropathy	—

Countries

Japan

Contacts

Public ContactKenji Hashimoto

National Cancer Center Hospital Breast and Medical Oncology Division

kehashim@ncc.go.jp03-3542-2511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026